Images List Premium Download Classic

Killer Cells

Killer Cells-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Modified natural killer cells and natural killer cell lines having increased cytotoxicity
Onkimmune Limited
June 08, 2017 - N°20170157230

Nk cells and nk cell lines are modified to increase cytotoxicity, wherein the cells and compositions thereof have a use in the treatment of cancer. Production of modified nk cells and nk cell lines is via genetic modification to remove checkpoint inhibitory receptor expression and/or add mutant (variant) trail ligand expression.
Smart car devices and de car polypeptides for treating disease and methods for enhancing immune ...
Chimera Bioengineering, Inc.
June 08, 2017 - N°20170157176

In an aspect, the present invention relates generally to the field of treating disease with car devices, smart car devices, de car devices, and/or smart-de car devices. The present invention also relates generally to the genetic modification of cytotoxic t-lymphocytes to reduce target cell killing by apoptosis and/or increase production of lytic proteins at desired times. In an ...
Ship inhibition to induce activation of natural killer cells
The Research Foundation For The State University Of New York
June 01, 2017 - N°20170151262

The present invention relates to the use or ship1 inhibitors and pan-ship1/2 inhibitors in various methods, including, without limitation, a method of inhibiting ship to induce broad activation of natural killer (nk) cells to treat various diseases.
Killer Cells Patent Pack
Download + patent application PDFs
Killer Cells Patent Applications
Download + Killer Cells-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Killer Cells-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Development of natural killer cells and functional natural killer cell lines
University Of Utah Research Foundation
March 23, 2017 - N°20170081637

The invention relates to natural killer cells and methods for the development of immortalized natural killer cells and use of the natural killer cells. A growth and culture system is described that supports increased natural killer cell development, and provides for the establishment of continuous natural killer cell lines. Additionally, the disclosed method for generating natural killer cells may be ...
Modified natural killer cells and uses thereof
St. Jude Children's Research Hospital, Inc.
March 16, 2017 - N°20170073638

The present invention provides, in certain aspects, a natural killer (nk) cell that expresses all or a functional portion of interleukin-15 (il-15), and methods for producing such cells. The invention further provides methods of using a natural killer (nk) cell that expresses all or a functional portion of interleukin-15 (il-15) to treat cancer in a subject or to enhance expansion ...
In vivo priming of natural killer cells
Immune Ventures Llc
March 16, 2017 - N°20170071982

The disclosure concerns a method for cancer treatment by in vivo priming and activation of natural killer cells for achieving tumor cell lysis. The method includes introducing into a patient a priming tumor cell preparation (ptcp) derived from a first tumor cell line, which is irradiated to inactivate the first tumor cells or a membrane preparation thereof, the first tumor ...
Killer Cells Patent Pack
Download + patent application PDFs
Killer Cells Patent Applications
Download + Killer Cells-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Killer Cells-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Modified natural killer cells, compositions and uses thereof
Fullhope Biomedical Co., Ltd.
November 10, 2016 - N°20160324895

Modified natural killer cells, pharmaceutical compositions comprising the modified natural killer cells and at least one pharmaceutically acceptable carrier or excipient, uses of the modified natural killer cells, and methods for identifying depleted natural killer cells and culturing the modified natural killer cells are provided.
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
Anthrogenesis Corporation
October 06, 2016 - N°20160287635

Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat ...
3d adcc nk facs assay
Hoffmann-la Roche Inc.
September 01, 2016 - N°20160252493

Herein is reported a cell analytical technology based on a three-dimensional spheroid/aggregate co-culture assay, wherein the spheroid or aggregate is formed of tumor and natural killer cells. This method is useful for the in vitro functional analysis of antibodies in single and high-throughput format.
Natural killer cells and methods for enhancing viability, proliferation and cytotoxicity of same following cryopreservation
Hoffmann-la Roche Inc.
June 30, 2016 - N°20160186138

The invention provides natural killer cells and improved methods for increasing natural killer cell viability, proliferation and cytotoxicity following cryopreservation.
Development of natural killer cells and functional natural killer cell lines
Hoffmann-la Roche Inc.
April 21, 2016 - N°20160109431

The invention relates to natural killer cells and methods for the development of immortalized natural killer cells and use of the natural killer cells. A growth and culture system is described that supports increased natural killer cell development, and provides for the establishment of continuous natural killer cell lines. Additionally, the disclosed method for generating natural killer cells may be ...
Formulation and method for preparing specific t cell, and method for preparing the formulation
Fullhope Biomedical Co., Ltd.
March 17, 2016 - N°20160074490

The present invention provides a formulation and method for preparing specific t cells, and a method for fabricating the formulation is also disclosed. The formulation can induce specific t cell responses, and comprises at least a cell population of dendritic killer cells presenting specific antigens. In addition, the method mentioned above for preparing specific t cells comprises following steps. A ...
Cytokine derived treatment with reduced vascular leak syndrome
Institut Gustave Roussy (igr)
March 10, 2016 - N°20160068584

The present invention relates to a pharmaceutical composition for treating a cancer or an infection in a subject by administrating an amount of an il-15 derivative conjugate so as to induce a proliferation of natural killer cells (nk cells) which is the same or higher than the one obtained with high dose of interleukin-2 (hdil-2); eventually associated with a pharmaceutically ...
Killer Cells Patent Pack
Download + patent application PDFs
Killer Cells Patent Applications
Download + Killer Cells-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Killer Cells-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Natural killer cells from placenta
Anthrogenesis Corporation
December 24, 2015 - N°20150366910

Provided herein are placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, combined natural killer cells from placenta and umbilical cord blood, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, and combined natural killer cells and combinations thereof, to suppress the growth ...
Method of providing cellular therapy using modified natural killer cells or t lymphocytes
Bloodcenter Research Foundation
September 17, 2015 - N°20150258143

A method of decreasing cytokine production and release is disclosed. In one embodiment, the method comprises the step of providing cytotoxic cells to a subject wherein the cells are preferably natural killer cells or t lymphocytes and are genetically modified to express a chimeric antigen receptor comprising a first element that is an extracellular antigen receptor and a second intracellular ...
Natural killer cells and uses thereof
Anthrogenesis Corporation
August 13, 2015 - N°20150225697

Provided herein are methods of producing natural killer (nk) cells and nk progenitor cell populations using a two-step expansion and differentiation method. Also provided herein are methods of producing populations of nk cells and nk progenitor cell populations using a three-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation using the nk cells, the ...
Industrial preparation of natural killer cells (nks) and injection using human allo-geneic karyocytes
Anthrogenesis Corporation
August 06, 2015 - N°20150218518

Disclosed is an industrial preparation of natural killer cells (nks) and an injection using human allogeneic karyocytes comprising: using umbilical cord blood and peripheral blood from legitimate sources as raw materials, obtaining stem cells by a method for extracting and separating karyocytes, or using ficoll or percoll density gradient centrifugation to isolate and screen out karyocytes; diluting the above-mentioned karyocytes ...
Medicament for wound treatment
Simu Trade Consulting Gmbh & Co. Leasing Kg
July 23, 2015 - N°20150202258

The invention relates to stathmin, stathmin, a nucleic acid encoding said stathmin or a cell expressing stathmin for use in the treatment of chronic wounds or disease- or medication-dependent impaired wound healing in a patient or for increasing or inducing the proliferation and/or migration of mesenchymal cells, of stem cells, for stimulating immune cells, preferably natural killer cells, for ...
Methods and compositions for natural killer cells
University Of Central Florida Research Foundation, Inc.
July 09, 2015 - N°20150190471

The application provides new compositions and methods for stimulating the production of natural killer (nk) cells in a subject. Nk cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of nk cells in proximity to a ...
Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear ...
Korea University Research And Business Foundation
June 04, 2015 - N°20150152387

The present invention relates to a method for inducing and expanding natural killer cells derived from peripheral blood mononuclear cells, which comprises co-culturing, as feeder cells, irradiated jurkat cells and irradiated epstein-barr virus transformed lymphocyte continuous line (ebv-lcl) cells in the presence of cytokines, along with peripheral blood mononuclear cells. According to the present invention, a large quantity of natural ...
Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts
Stem Cell & Regenerative Medicine International, Inc.
May 21, 2015 - N°20150140657

This invention provides methods of generating natural killer (nk) cells and dendritic cells (dcs). The methods utilize human hemangioblasts as intermediate cells to generate the nk cells and dcs. In various embodiments, the methods do not require the use of stromal feeder layers.
Loading